|
"lan k h"的相關文件
顯示項目 91-103 / 103 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T04:46:08Z |
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|
Nagata, Y.;Lan, K.-H.;Zhou, X.;Tan, M.;Esteva, F.J.;Sahin, A.A.;Klos, K.S.;Li, P.;Monia, B.P.;Nguyen, N.T.;Hortobagyi, G.N.;Hung, M.-C.;Yu, D.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2018-09-10T04:46:08Z |
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers
|
Zhou, X.;Tan, M.;Hawthorne, V.S.;Klos, K.S.;Lan, K.-H.;Yang, Y.;Yang, W.;Smith, T.L.;Shi, D.;Yu, D.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2018-09-10T04:07:03Z |
Phosphorylation on tyrosine-15 of p34Cdc2 by ErbB2 inhibits p34Cdc2 activation and is involved in resistance to taxol-induced apoptosis
|
Tan, M.;Jing, T.;Lan, K.-H.;Neal, C.L.;Li, P.;Lee, S.;Fang, D.;Nagata, Y.;Liu, J.;Arlinghaus, R.;Hung, M.-C.;Yu, D.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2018-09-10T04:07:03Z |
Localizing the EGF receptor (multiple letters) [1]
|
Oksvold, M.;Huitfeldt, H.;Stang, E.;Madshus, I.;Bourguignon, L.;Lan, K.-H.;Singleton, P.;Lins, S.-Y.;Yu, D.;Hung, M.-C.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2018-09-10T04:07:03Z |
Enhanced sensitization to Taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells
|
Lee, S.;Yang, W.;Lan, K.-H.;Sellappan, S.;Klos, K.;Hortobagyi, G.;Hung, M.-C.;Yu, D.; KENG-HSUEH LAN |
| 臺大學術典藏 |
2018 |
Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer
|
Chen W.-Y.;Wu C.-T.;Wang C.-W.;Lan K.-H.;Liang H.-K.;Huang B.-S.;Yih-Leong Chang;Kuo S.-H.;Cheng A.-L.; Chen W.-Y.; Wu C.-T.; Wang C.-W.; Lan K.-H.; Liang H.-K.; Huang B.-S.; YIH-LEONG CHANG; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2017 |
Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia
|
HWEI-FANG TIEN; Chou W.-C.; Chiu Y.-C.; Chuang P.-H.; Tseng M.-H.; Kao C.-J.; Kuo Y.-Y.; Tzeng Y.-S.; Chen T.-C.; Lan K.-H.; Hou H.-A.; Kuo Y.-Y.; Hsu Y.-C.; Li Y.-H.; Lin C.-C. |
| 臺大學術典藏 |
2016 |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Liu S.-P.; Lai M.-K.; Pu Y.-S.; CHIA-HSIEN CHENG; Yu H.-J.; Chen C.-H.; Lan K.-H.; Wang C.-C.; Huang C.-Y.; Hou W.-H.; Hou W.-H.;Huang C.-Y.;Wang C.-C.;Lan K.-H.;Chen C.-H.;Yu H.-J.;Liu S.-P.;Lai M.-K.;Pu Y.-S.;Chia-Hsien Cheng |
| 臺大學術典藏 |
2015 |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; CHIA-HSIEN CHENG; Lan K.-H.; Wang C.-C.; Wang Y.-J.;Huang C.-Y.;Hou W.-H.;Wang C.-C.;Lan K.-H.;Chen C.-H.;Yu H.-J.;Lai M.-K.;Cheng A.-L.;Liu S.-P.;Pu Y.-S.;Chia-Hsien Cheng; Wang Y.-J.; Huang C.-Y.; Hou W.-H. |
| 東海大學 |
2013 |
Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination
|
Lee, W.-J.; Lan, K.-H.; Chou, C.-T.; Yi, Y.-C.; Chen, W.-C.; Pan, H.-C.; Peng, Y.-C.; Wang, K.-B.; Chen, Y.-C.; Chao, T.-H.; Tien, H.-R.; Sheu, W.H.H.; Sheu, M.-L. |
| 臺大學術典藏 |
2013 |
Clinicopathologic features and responses to radiotherapy of myeloid sarcoma
|
Chen W.-Y.; Wang C.-W.; Chang C.-H.; Liu H.-H.; Lan K.-H.; Tang J.-L.; HWEI-FANG TIEN; Kuo S.-H.; Cheng A.-L. |
| 國立臺灣大學 |
2012 |
Medulloblastoma in adults Treatment outcome, relapse patterns, and prognostic factors
|
Lai, S. -F.; Wang, C. -W.; Chen, Y. -H.; Lan, K. -H.; Cheng, J. C. -H.; Cheng, A. -L.; Kuo, S. -H.; 郭頌鑫; 鄭安理; 成佳憲; 陳育瑄; 藍耿學; 王駿瑋 |
| 亞洲大學 |
2004-04 |
PTEN activation contributes to tumor inhibition by trastuzumab and loss of PTEN predicts trastuzumab resistance in patients
|
Nagata, Y.;Lan, K-H.;Zhou, X.;Tan, M.;Esteva, F. J.;Sahin, A. A.;Klos, K. S.;Li, P.;Monia, B. P.;Nguyen, N. T.;Hortobagyi, G. N.;Mien-Chie Hung;Yu, D. |
顯示項目 91-103 / 103 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
|
